Back

Antithrombotic Strategies After RVOT surgical or percutaneous Interventions: Prevention and Management of Valve Thrombosis

10 April 2026 (13:00 - 13:25)
Organised by: Logo
Seminar Presentation Part of: Right ventricle outflow tract: Valving & Interventions Adult Congenital Heart Disease (ACHD) Open Access EuroACHD 2026 WG on Adult Congenital Heart Disease

3 More presentations in this session

Presentation thumbnail
What’s New After the Latest RVOT Valving Guidelines?
Slides
Presentation thumbnail
Percutaneous Pulmonary Valve Implantation in 2026: Planning, Devices, and Outcomes
Slides
Presentation thumbnail
Surgical RVOT Valving in Adults: Outdated or Still Needed? Managing Patients with Prior RVOT Stents
Slides

Access the full session

Session thumbnail
Right ventricle outflow tract: Valving & Interventions

The Event

Event poster

EuroACHD 2026

10 April 2026 13:00 CET
You may be interested in
thumbnail
Congress Session
Failing valves and beyond
19 May 2025
thumbnail
Congress Presentation
Anticoagulation management of heartware left ventricular assist device thrombosis: comparison of heparin and bivalirudin
3 September 2019
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Treatment of acute heart failure in adult congenital heart disease: focus on the right heart
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources